Immune defects observed in patients with primary malignant brain tumors
β Scribed by Amy R Dix; William H Brooks; Thomas L Roszman; Lorri A Morford
- Book ID
- 114138985
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 207 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0165-5728
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Patients with primary malignant brain tumors (pmbt) often have neurobehavioral deficits due to the tumor, subsequent surgery, and therapies that interfere with their ability to live independently or work. previous studies have shown that such patients generally have a progressive dec
Several studies report coexistent or subsequent primary tumors (SPT) among patients with malignant melanoma (MM), with the rate of incidence ranging from 1.5-20% depending on the sample size and the length and completeness of follow-up. ## METHODS. The authors followed a cohort of patients with c
## Abstract Sera from 50 patients with Hodgkin's disease, 78 patients with nonβHodgkin nonβleukemic malignant lymphomas, and 75 patients with different types of solid malignant tumors were investigated for the presence of immune complexes using the (^125^I) C1qβbinding test. All patients were untre